CKD Bio Corp
KRX:063160

Watchlist Manager
CKD Bio Corp Logo
CKD Bio Corp
KRX:063160
Watchlist
Price: 20 450 KRW Market Closed
Market Cap: 112.3B KRW

CKD Bio Corp
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

CKD Bio Corp
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
CKD Bio Corp
KRX:063160
Free Cash Flow
-â‚©2B
CAGR 3-Years
42%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Free Cash Flow
-â‚©75.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Free Cash Flow
â‚©88.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Free Cash Flow
â‚©85.4B
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Free Cash Flow
-â‚©51.2B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Free Cash Flow
â‚©12.3B
CAGR 3-Years
-25%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

CKD Bio Corp
Glance View

Market Cap
112.2B KRW
Industry
Pharmaceuticals

CKD Bio Corp. engages in the development and manufacture of active pharmaceutical ingredients. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-12-11. The firm mainly provides antibiotic ingredients, consisting of demethylchlortetracyclines (DMCTs) and rifampicins. The company also provides immunosuppressive agents, including cyclosporin and tacrolimus; remedies for diabetes, such as acarbose, and potassium clavulanate used for beta-lactam inhibitors. The firm distributes its products within domestic market and to overseas markets, such as America, China, Europe, Africa, Southeast Asia, Latin America and the Middle East.

Intrinsic Value
18 032.84 KRW
Overvaluation 12%
Intrinsic Value
Price

See Also

What is CKD Bio Corp's Free Cash Flow?
Free Cash Flow
-2B KRW

Based on the financial report for Jun 30, 2025, CKD Bio Corp's Free Cash Flow amounts to -2B KRW.

What is CKD Bio Corp's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
49%

Over the last year, the Free Cash Flow growth was -294%. The average annual Free Cash Flow growth rates for CKD Bio Corp have been 42% over the past three years , 49% over the past five years .

Back to Top